Enochian Biosciences

ENOB NASDAQ
5.43
+0.22
+4.22%
Closed 16:00 06/21 EDT
Open
5.21
Prev Close
5.21
High
5.50
Low
5.01
Volume
62.49K
Avg Vol (3M)
36.32K
52 Week High
9.50
52 Week Low
3.320
% Turnover
0.16%
Market Cap
210.63M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Enochian Biosciences ENOB stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Enochian Biosciences Inc, formerly DanDrit Biotech USA, Inc., is a Denmark-based biotechnology company. The Company focuses on developing vaccine against colorectal cancer. It has developed various vaccines that are used in various clinical trials in Europe and Asia, including MelCancerVac (MCV) for treatment of cancer (one phase I/II trial in Denmark and two phase II trials in Denmark and Singapore), Tolerogenic (producing immunologic tolerance) dendritic cell (TDC) (pre-clinical stage in Denmark), and Melvaccine (MV), a melanoma cell lysate used as standalone vaccine (pre-clinical state in Denmark). The Company offers MCV platform technology, which is a cellular immunotherapy for treatment of cancer. Also, the Company develops gene therapies for patients with human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS).
MORE >

Recently

Name
Price
%Change